Alterations in transformation efficiency by the ADPRT-inhibitor 3-aminobenzamide are oncogene specific

Area of Science:

• Molecular biology
• Cell biology
• Oncology

Background:

• Cell transformation is a key step in cancer development.
• Oncogenes drive cellular transformation.
• Poly(ADP-ribose)transferase (ADPRT) is involved in DNA repair and other cellular processes.

Purpose of the Study:

• To investigate the role of ADPRT in oncogene-induced cell transformation.
• To determine the effect of the ADPRT inhibitor 3-aminobenzamide on NIH 3T3 cell transformation.

Main Methods:

• NIH 3T3 cells were transfected with various oncogenes (ras, v-src, v-mos, v-raf, v-fos) or SV40 DNA.
• Cells were treated with 3-aminobenzamide, an ADPRT inhibitor.
• Cell transformation was assessed by focus formation assays.

Main Results:

• 3-aminobenzamide inhibited transformation induced by ras, v-src, v-mos, and v-raf oncogenes.
• No significant effect was observed on v-fos-mediated transformation.
• SV40 DNA-mediated transformation efficiency was increased approximately two-fold.
• The inhibitory effect on ras-mediated transformation occurred between days 3 and 7 post-transfection.

Conclusions:

• ADPRT activity is implicated in the transformation process mediated by certain oncogenes.
• Inhibition of ADPRT may represent a potential therapeutic strategy for cancers driven by these oncogenes.
• The specific role of ADPRT in transformation may vary depending on the oncogene involved.